These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 10465087)

  • 41. Stevens-Johnson syndrome in HIV patients treated with nevirapine: two case reports.
    Dodi F; Alessandrini A; Camera M; Gaffuri L; Morandi N; Pagano G
    AIDS; 2002 May; 16(8):1197-8. PubMed ID: 12004287
    [No Abstract]   [Full Text] [Related]  

  • 42. US expert panel reaffirms benefit of perinatal zidovudine.
    Rowe PM
    Lancet; 1997 Jan; 349(9047):258. PubMed ID: 9014924
    [No Abstract]   [Full Text] [Related]  

  • 43. In utero nucleoside reverse transcriptase inhibitor exposure and cancer in HIV-uninfected children: an update from the pediatric AIDS clinical trials group 219 and 219C cohorts.
    Brogly S; Williams P; Seage GR; Van Dyke R
    J Acquir Immune Defic Syndr; 2006 Apr; 41(4):535-6. PubMed ID: 16652068
    [No Abstract]   [Full Text] [Related]  

  • 44. Resolution of disseminated molluscum contagiosum with Highly Active Anti-Retroviral Therapy (HAART) in patients with AIDS.
    Calista D; Boschini A; Landi G
    Eur J Dermatol; 1999; 9(3):211-3. PubMed ID: 10210787
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of late-state HIV infection.
    Millard PS
    J Fam Pract; 1997 Feb; 44(2):132-4. PubMed ID: 9040512
    [No Abstract]   [Full Text] [Related]  

  • 46. Zidovudine toxicity in uninfected healthcare workers. Italian Registry of Antiretroviral Prophylaxis.
    Ippolito G; Puro V
    Am J Med; 1997 May; 102(5B):58-62. PubMed ID: 9845498
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A randomized trial of interferon-alpha2a and zidovudine versus bleomycin and zidovudine for AIDS-related Kaposi's sarcoma. Swiss HIV Cohort Study.
    Opravil M; Hirschel B; Bucher HC; Lüthy R
    Int J STD AIDS; 1999 Jun; 10(6):369-75. PubMed ID: 10414879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination therapy with alpha interferon and lamivudine in patients with chronic hepatitis B and HIV infection.
    Nasti G; di Gennaro G; Donada C; Donadon V; Tirelli U
    AIDS; 1999 Oct; 13(15):2176-8. PubMed ID: 10546877
    [No Abstract]   [Full Text] [Related]  

  • 49. Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission.
    Giaquinto C; De Romeo A; Giacomet V; Rampon O; Ruga E; Burlina A; De Rossi A; Sturkenboom M; D'Elia R
    AIDS; 2001 May; 15(8):1074-5. PubMed ID: 11399997
    [No Abstract]   [Full Text] [Related]  

  • 50. Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
    Prescrire Int; 2004 Oct; 13(73):180-2. PubMed ID: 15499699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Antiretroviral therapy of HIV infections. New recommendations by the International AIDS Society].
    Allouch H
    Presse Med; 1998 Nov; 27(34):1739-41. PubMed ID: 9835934
    [No Abstract]   [Full Text] [Related]  

  • 52. Resistance profile of the human immunodeficiency virus type 1 reverse transcriptase inhibitor abacavir (1592U89) after monotherapy and combination therapy. CNA2001 Investigative Group.
    Harrigan PR; Stone C; Griffin P; Nájera I; Bloor S; Kemp S; Tisdale M; Larder B
    J Infect Dis; 2000 Mar; 181(3):912-20. PubMed ID: 10720512
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A new HAART on the horizon says the proof is in the potency.
    AIDS Alert; 1999 Apr; 14(4):37-9. PubMed ID: 11366218
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gene expression and immunohistochemistry in adipose tissue of HIV type 1-infected patients with nucleoside analogue reverse-transcriptase inhibitor-associated lipoatrophy.
    Sievers M; Walker UA; Sevastianova K; Setzer B; Wågsäter D; Eriksson P; Yki-Järvinen H; Sutinen J
    J Infect Dis; 2009 Jul; 200(2):252-62. PubMed ID: 19519254
    [TBL] [Abstract][Full Text] [Related]  

  • 55. AVANTI 2. Randomized, double-blind trial to evaluate the efficacy and safety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients.
    AIDS; 2000 Mar; 14(4):367-74. PubMed ID: 10770538
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
    Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
    West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidental treatment of hepatitis B virus infection in an AIDS patient.
    Warner D
    AIDS Read; 2000 Jun; 10(6):376. PubMed ID: 10881369
    [No Abstract]   [Full Text] [Related]  

  • 58. Nucleoside reverse transcriptase inhibitors, mitochondrial DNA and AIDS therapy.
    Lewis W
    Antivir Ther; 2005; 10 Suppl 2():M13-27. PubMed ID: 16152703
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative studies of two-times-daily versus three-times-daily indinavir in combination with zidovudine and lamivudine.
    Haas DW; Arathoon E; Thompson MA; de Jesus Pedro R; Gallant JE; Uip DE; Currier J; Noriega LM; Lewi DS; Uribe P; Benetucci L; Cahn P; Paar D; White AC; Collier AC; Ramirez-Ronda CH; Harvey C; Chung MO; Mehrotra D; Chodakewitz J; Nguyen BY;
    AIDS; 2000 Sep; 14(13):1973-8. PubMed ID: 10997402
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antiretroviral therapy 2010 update: current practices and controversies.
    Grant M; Samuel R; Bettiker RL; Suh B
    Arch Pharm Res; 2011 Jul; 34(7):1045-53. PubMed ID: 21811910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.